These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 29259166)
1. Inhibition of autophagy delays motoneuron degeneration and extends lifespan in a mouse model of spinal muscular atrophy. Piras A; Schiaffino L; Boido M; Valsecchi V; Guglielmotto M; De Amicis E; Puyal J; Garcera A; Tamagno E; Soler RM; Vercelli A Cell Death Dis; 2017 Dec; 8(12):3223. PubMed ID: 29259166 [TBL] [Abstract][Full Text] [Related]
2. Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy. Dachs E; Piedrafita L; Hereu M; Esquerda JE; Calderó J Neuroscience; 2013 Oct; 250():417-33. PubMed ID: 23876328 [TBL] [Abstract][Full Text] [Related]
3. Skeletal muscle DNA damage precedes spinal motor neuron DNA damage in a mouse model of Spinal Muscular Atrophy (SMA). Fayzullina S; Martin LJ PLoS One; 2014; 9(3):e93329. PubMed ID: 24667816 [TBL] [Abstract][Full Text] [Related]
4. Spinal Muscular Atrophy autophagy profile is tissue-dependent: differential regulation between muscle and motoneurons. Sansa A; Hidalgo I; Miralles MP; de la Fuente S; Perez-Garcia MJ; Munell F; Soler RM; Garcera A Acta Neuropathol Commun; 2021 Jul; 9(1):122. PubMed ID: 34217376 [TBL] [Abstract][Full Text] [Related]
6. Role of autophagy in the bimodal stage after spinal cord ischemia reperfusion injury in rats. Fang B; Li XQ; Bao NR; Tan WF; Chen FS; Pi XL; Zhang Y; Ma H Neuroscience; 2016 Jul; 328():107-16. PubMed ID: 27109922 [TBL] [Abstract][Full Text] [Related]
7. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog. Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872 [TBL] [Abstract][Full Text] [Related]
8. Agonist of growth hormone-releasing hormone improves the disease features of spinal muscular atrophy mice. Boido M; Gesmundo I; Caretto A; Pedrolli F; Schellino R; Leone S; Cai R; Sha W; Ghigo E; Schally AV; Vercelli A; Granata R Proc Natl Acad Sci U S A; 2023 Jan; 120(2):e2216814120. PubMed ID: 36603028 [TBL] [Abstract][Full Text] [Related]
9. Survival motor neuron protein reduction deregulates autophagy in spinal cord motoneurons in vitro. Garcera A; Bahi N; Periyakaruppiah A; Arumugam S; Soler RM Cell Death Dis; 2013 Jun; 4(6):e686. PubMed ID: 23788043 [TBL] [Abstract][Full Text] [Related]
10. Autophagy activation is associated with neuroprotection against apoptosis via a mitochondrial pathway in a rat model of subarachnoid hemorrhage. Jing CH; Wang L; Liu PP; Wu C; Ruan D; Chen G Neuroscience; 2012 Jun; 213():144-53. PubMed ID: 22521819 [TBL] [Abstract][Full Text] [Related]
11. Selective loss of alpha motor neurons with sparing of gamma motor neurons and spinal cord cholinergic neurons in a mouse model of spinal muscular atrophy. Powis RA; Gillingwater TH J Anat; 2016 Mar; 228(3):443-51. PubMed ID: 26576026 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms involved in spinal cord central synapse loss in a mouse model of spinal muscular atrophy. Tarabal O; Caraballo-Miralles V; Cardona-Rossinyol A; Correa FJ; Olmos G; Lladó J; Esquerda JE; Calderó J J Neuropathol Exp Neurol; 2014 Jun; 73(6):519-35. PubMed ID: 24806302 [TBL] [Abstract][Full Text] [Related]
13. A Perturbed MicroRNA Expression Pattern Characterizes Embryonic Neural Stem Cells Derived from a Severe Mouse Model of Spinal Muscular Atrophy (SMA). Luchetti A; Ciafrè SA; Murdocca M; Malgieri A; Masotti A; Sanchez M; Farace MG; Novelli G; Sangiuolo F Int J Mol Sci; 2015 Aug; 16(8):18312-27. PubMed ID: 26258776 [TBL] [Abstract][Full Text] [Related]
14. Normalization of Patient-Identified Plasma Biomarkers in SMNΔ7 Mice following Postnatal SMN Restoration. Arnold WD; Duque S; Iyer CC; Zaworski P; McGovern VL; Taylor SJ; von Herrmann KM; Kobayashi DT; Chen KS; Kolb SJ; Paushkin SV; Burghes AH PLoS One; 2016; 11(12):e0167077. PubMed ID: 27907033 [TBL] [Abstract][Full Text] [Related]
15. Astrocyte-produced miR-146a as a mediator of motor neuron loss in spinal muscular atrophy. Sison SL; Patitucci TN; Seminary ER; Villalon E; Lorson CL; Ebert AD Hum Mol Genet; 2017 Sep; 26(17):3409-3420. PubMed ID: 28637335 [TBL] [Abstract][Full Text] [Related]
16. Increased levels of UCHL1 are a compensatory response to disrupted ubiquitin homeostasis in spinal muscular atrophy and do not represent a viable therapeutic target. Powis RA; Mutsaers CA; Wishart TM; Hunter G; Wirth B; Gillingwater TH Neuropathol Appl Neurobiol; 2014 Dec; 40(7):873-87. PubMed ID: 25041530 [TBL] [Abstract][Full Text] [Related]
17. Central and peripheral defects in motor units of the diaphragm of spinal muscular atrophy mice. Neve A; Trüb J; Saxena S; Schümperli D Mol Cell Neurosci; 2016 Jan; 70():30-41. PubMed ID: 26621405 [TBL] [Abstract][Full Text] [Related]
18. Intracellular pathways involved in cell survival are deregulated in mouse and human spinal muscular atrophy motoneurons. Sansa A; de la Fuente S; Comella JX; Garcera A; Soler RM Neurobiol Dis; 2021 Jul; 155():105366. PubMed ID: 33845129 [TBL] [Abstract][Full Text] [Related]
19. Spinal astrocyte dysfunction drives motor neuron loss in late-onset spinal muscular atrophy. Schmitt LI; David C; Steffen R; Hezel S; Roos A; Schara-Schmidt U; Kleinschnitz C; Leo M; Hagenacker T Acta Neuropathol; 2023 May; 145(5):611-635. PubMed ID: 36930296 [TBL] [Abstract][Full Text] [Related]
20. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy. Riessland M; Ackermann B; Förster A; Jakubik M; Hauke J; Garbes L; Fritzsche I; Mende Y; Blumcke I; Hahnen E; Wirth B Hum Mol Genet; 2010 Apr; 19(8):1492-506. PubMed ID: 20097677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]